Predicting Recurrence in Pancreatic Ductal Adenocarcinoma after Radical Surgery Using an AX-Unet Pancreas Segmentation Model and Dynamic Nomogram

被引:0
|
作者
Ni, Haixu [1 ,2 ]
Zhou, Gonghai [3 ]
Chen, Xinlong [1 ]
Ren, Jing [4 ]
Yang, Minqiang [3 ]
Zhang, Yuhong [3 ]
Zhang, Qiyu [1 ,2 ]
Zhang, Lei [1 ,2 ]
Mao, Chengsheng [5 ]
Li, Xun [1 ,2 ,6 ]
机构
[1] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Peoples R China
[2] Lanzhou Univ, Hosp 1, Dept Gen Surg, Lanzhou 730000, Peoples R China
[3] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China
[4] Lanzhou Univ, Reprod Med Hosp, Hosp 1, Lanzhou 730000, Peoples R China
[5] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[6] Key Lab Biotherapy & Regenerat Med Gansu Prov, Lanzhou 730000, Peoples R China
来源
BIOENGINEERING-BASEL | 2023年 / 10卷 / 07期
关键词
pancreatic ductal adenocarcinoma; pancreas image segmentation; recurrence; pancreatectomy; radiomics;
D O I
10.3390/bioengineering10070828
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This study aims to investigate the reliability of radiomic features extracted from contrast-enhanced computer tomography (CT) by AX-Unet, a pancreas segmentation model, to analyse the recurrence of pancreatic ductal adenocarcinoma (PDAC) after radical surgery. In this study, we trained an AX-Unet model to extract the radiomic features from preoperative contrast-enhanced CT images on a training set of 205 PDAC patients. Then we evaluated the segmentation ability of AX-Unet and the relationship between radiomic features and clinical characteristics on an independent testing set of 64 patients with clear prognoses. The lasso regression analysis was used to screen for variables of interest affecting patients' post-operative recurrence, and the Cox proportional risk model regression analysis was used to screen for risk factors and create a nomogram prediction model. The proposed model achieved an accuracy of 85.9% for pancreas segmentation, meeting the requirements of most clinical applications. Radiomic features were found to be significantly correlated with clinical characteristics such as lymph node metastasis, resectability status, and abnormally elevated serum carbohydrate antigen 19-9 (CA 19-9) levels. Specifically, variance and entropy were associated with the recurrence rate (p < 0.05). The AUC for the nomogram predicting whether the patient recurred after surgery was 0.92 (95% CI: 0.78-0.99) and the C index was 0.62 (95% CI: 0.48-0.78). The AX-Unet pancreas segmentation model shows promise in analysing recurrence risk factors after radical surgery for PDAC. Additionally, our findings suggest that a dynamic nomogram model based on AX-Unet can provide pancreatic oncologists with more accurate prognostic assessments for their patients.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection
    He, Chaobin
    Sun, Shuxin
    Zhang, Yu
    Lin, Xiaojun
    Li, Shengping
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [2] Development and validation of a nomogram for predicting survival in patients with pancreatic ductal adenocarcinoma after radical pancreatoduodenectomy
    Wang, Yanwei
    Cui, Chenghao
    Yu, Qiang
    Li, Mingtai
    Liang, Yurong
    ONCOLOGIE, 2023, 25 (01) : 51 - 59
  • [3] A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
    He, Chaobin
    Huang, Xin
    Zhang, Yu
    Cai, Zhiyuan
    Lin, Xiaojun
    Li, Shengping
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [4] A radiomics nomogram model for predicting prognosis of pancreatic ductal adenocarcinoma after high-intensity focused ultrasound surgery
    Shao, Changjie
    Zhang, Juntao
    Guo, Jing
    Zhang, Liang
    Zhang, Yuhan
    Ma, Leiyuan
    Gong, Chuanxin
    Tian, Yaqi
    Chen, Jingjing
    Yu, Ning
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2023, 40 (01)
  • [5] Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma
    Nappo, Gennaro
    Donisi, Greta
    Capretti, Giovanni
    Ridolfi, Cristina
    Pagnanelli, Michele
    Nebbia, Martina
    Bozzarelli, Silvia
    Petitti, Tommasangelo
    Gavazzi, Francesca
    Zerbi, Alessandro
    CURRENT ONCOLOGY, 2023, 30 (04) : 3708 - 3720
  • [6] Factors predicting recurrence after left‑sided pancreatectomy for pancreatic ductal adenocarcinoma
    Tao Xia
    Peng Xu
    Yiping Mou
    Xizhou Zhang
    Shihao Song
    Yucheng Zhou
    Chao Lu
    Qicong Zhu
    Yunyun Xu
    Weiwei Jin
    Yuanyu Wang
    World Journal of Surgical Oncology, 21
  • [7] Postoperative serum tumor markers-based nomogram predicting early recurrence for patients undergoing radical resections of pancreatic ductal adenocarcinoma
    He, Hang
    Zou, Cai-Feng
    Yang, Feng
    Di, Yang
    Jin, Chen
    Fu, De-Liang
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (10):
  • [8] Metachronous Secondary Lesions and Recurrence in the Remnant Pancreas After Pancreatectomy for Pancreatic Ductal Adenocarcinoma
    Gotoh, Y.
    Ohtsuka, T.
    Nakamura, S.
    Nakashima, Y.
    Date, K.
    Fujimoto, T.
    Mochidome, N.
    Mori, Y.
    Sadakari, Y.
    Nakata, K.
    Miyasaka, Y.
    Ohuchida, K.
    Manabe, T.
    Nagai, E.
    Oda, Y.
    Nakamura, M.
    PANCREAS, 2016, 45 (10) : 1509 - 1509
  • [9] Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma
    Wen, Chenlei
    Deng, XiaXing
    Ren, Dandan
    Song, Xue
    Chen, Hao
    Wang, Jiancheng
    Jin, Jiabin
    Cheng, Dongfeng
    Xu, Zhiwei
    Zhang, Jun
    Xie, Junjie
    Qi, Wenjing
    Gu, Jiangning
    Peng, Chenghong
    Chen, Dan
    Chen, Shi
    Shen, Baiyong
    Zhan, Qian
    CANCER MEDICINE, 2020, 9 (20): : 7626 - 7636
  • [10] Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
    Tong, Jingshu
    Jiang, Wei
    Mao, Shuqi
    Wu, Shengdong
    Lu, Caide
    FRONTIERS IN ONCOLOGY, 2022, 12